Clinical Trial Update: Antimicrobial Photodynamic Therapy With Erythrosine and Blue Light on Dental Biofilm Bacteria [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating antimicrobial photodynamic therapy with erythrosine and blue light to address dental plaque biofilm bacteria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Plaque

Drugs mentioned

• erythrosine + blue light photodynamic therapy

Snippet

Sponsor: University of Nove de Julho | Conditions: Dental Plaque | Phase 1, Phase 2 | Status: UNKNOWN